期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
ALKBH2基因RNA干扰慢病毒载体的构建与鉴定 被引量:4
1
作者 龚隽 葛京平 +1 位作者 杨斌 孙颖浩 《医学研究生学报》 CAS 北大核心 2014年第5期456-459,共4页
目的 ALKBH2基因高表达于尿路上皮肿瘤,RNA干扰(RNA interference,RNAi)技术难以稳定均一性的下调靶基因。文中旨在构建人源ABH2基因shRNA干扰慢病毒表达载体并进行鉴定。方法选取ABH2基因,分析该基因的编码区序列,进行单链oligo的设计... 目的 ALKBH2基因高表达于尿路上皮肿瘤,RNA干扰(RNA interference,RNAi)技术难以稳定均一性的下调靶基因。文中旨在构建人源ABH2基因shRNA干扰慢病毒表达载体并进行鉴定。方法选取ABH2基因,分析该基因的编码区序列,进行单链oligo的设计及合成,利用PCR对合成的oligo进行拼接反应,将合成好的序列装入pcDNA3.1(+)载体并转化至感受态细胞DH5α,测序鉴定重组克隆中基因序列后构建表达载体pcDNA3.1(+)/ABH2。根据不同的载体分为4组:siRNA-468组、siRNA-571组、siRNA-662组和对照组。根据靶基因序列设计并合成3对shRNA,构建入U6载体。将shRNA载体分别与表达载体共转染入HEK293细胞,通过QPCR检测筛选出最优干扰序列。将筛选到最有效的shRNA-571干扰序列构建入慢病毒载体pL/shRNA/F载体,用构建的慢病毒干扰载体和包装质粒共转染293T细胞,包装病毒,收集病毒原液,超速离心浓缩,并测定滴度。将LV-shRNA-571与过表达载体pcDNA3.1(+)/ABH2共转染肾癌细胞株ACHN,通过QPCR鉴定干扰效果。结果克隆测序验证无误,慢病毒载体构建成功。转染实验48 h后,收集293细胞分泌的病毒上清测定病毒的滴度为1.1×108TU/mL。对照组ABH2 mRNA相对表达量为0.785±0.082,siRNA-571组为0.078±0.006,RNAi后ABH2基因的mRNA表达水平(0.078±0.006)与对照组(0.785±0.082)相比显著降低(P<0.01),慢病毒PL/shRNA/F-ALKBH2-571对目的基因ABH2的干扰效率为92.2%。结论成功构建ABH2基因RNAi慢病毒载体并得到鉴定。 展开更多
关键词 RNA干扰 alkbh2基因 慢病毒
下载PDF
The complex structures of ALKBH2 mutants cross-linked to dsDNA reveal the conformational swing of β-hairpin
2
作者 CHEN BaoEn GAN JianHua YANG CaiGuang 《Science China Chemistry》 SCIE EI CAS 2014年第2期307-313,共7页
Mammalian AlkB homologue 2(ALKBH2)is the primary housekeeping DNA demethylase,effectively repairing endogenously formed methylated lesions in double-stranded DNA.Our previous studies demonstrated that a hydrophobicβ-... Mammalian AlkB homologue 2(ALKBH2)is the primary housekeeping DNA demethylase,effectively repairing endogenously formed methylated lesions in double-stranded DNA.Our previous studies demonstrated that a hydrophobicβ-hairpin motif of ALKBH2 could play crucial roles in base-pair stability interrogation and damaged base flipping.Using chemical cross-linking strategy,we obtained two crystal structures of human ALKBH2 mutant bound to duplex DNA.The structural analysis suggests that theβ-hairpin motif is flexible in conformation and is likely to slide along the DNA duplex in local regions to search for damaged base.This study provides a new mechanistic insight into DNA damage detection by ALKBH2. 展开更多
关键词 DNA repair alkbh2 chemical cross-linking B-hairpin motif damage detection
原文传递
Boosting 5-ALA-based photodynamic therapy by a liposomal nanomedicine through intracellular iron ion regulation 被引量:2
3
作者 Airong Li Chenglin Liang +5 位作者 Lihua Xu Yiyang Wang Wei Liu Kaixiang Zhang Junjie Liu Jinjin Shi 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2021年第5期1329-1340,共12页
5-Aminolevulinic acid(5-ALA)has been approved for clinical photodynamic therapy(PDT)due to its negligible photosensitive toxicity.However,the curative effect of 5-ALA is restricted by intracellular biotransformation i... 5-Aminolevulinic acid(5-ALA)has been approved for clinical photodynamic therapy(PDT)due to its negligible photosensitive toxicity.However,the curative effect of 5-ALA is restricted by intracellular biotransformation inactivation of 5-ALA and potential DNA repair of tumor cells.Inspired by the crucial function of iron ions in 5-ALA transformation and DNA repair,a liposomal nanomedicine(MFLs@5-ALA/DFO)with intracellular iron ion regulation property was developed for boosting the PDT of 5-ALA,which was prepared by co-encapsulating 5-ALA and DFO(deferoxamine,a special iron chelator)into the membrane fusion liposomes(MFLs).MFLs@5-ALA/DFO showed an improved pharmaceutical behavior and rapidly fused with tumor cell membrane for 5-ALA and DFO co-delivery.MFLs@5-ALA/DFO could efficiently reduce iron ion,thus blocking the biotransformation of photosensitive protoporphyrin IX(Pp IX)to heme,realizing significant accumulation of photosensitivity.Meanwhile,the activity of DNA repair enzyme was also inhibited with the reduction of iron ion,resulting in the aggravated DNA damage in tumor cells.Our findings showed MFLs@5-ALA/DFO had potential to be applied for enhanced PDT of 5-ALA. 展开更多
关键词 5-Aminolevulinic acid Biotransformation interference Iron ion regulation DNA repair inhibition alkbh2 Membrane fusion liposomes Photodynamic therapy Drug delivery
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部